Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Ernesta Mačionienė; Martynas Simanavičius; Monika Vitkauskaitė; Alvita Vickienė; Roberta Staučė; Artūras Vinikovas; Marius Miglinas

doi:10.12659/AOT.944762

15 October 2024 : Original article

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Ernesta Mačionienė

^1ABCDEFG*, Martynas Simanavičius^2BE, Monika Vitkauskaitė^1BC, Alvita Vickienė^1B, Roberta Staučė^3B, Artūras Vinikovas^3B, Marius Miglinas^1ADEF

DOI: 10.12659/AOT.944762

Ann Transplant 2024; 29:e944762

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 The logarythmic values of CXCL9/cre (A) and CXCL10/cre (B) levels in normal histology, rejection and other histology (eg, global glomerulosclerosis, recurrent glomerulonephritis, amyloidosis) cases. Both chemokines are significantly increased in rejection groups compared to other groups. The figure was created with SPSS 29.0 (SPSS, Inc, Chicago, IL, USA).

Back to the Article

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Your Privacy